Skip to main content
Fig. 4 | Journal of Hematology & Oncology

Fig. 4

From: Small molecule inhibitors targeting m6A regulators

Fig. 4

The m6A modification regulates cancer development by mediating different signaling pathways. For BC, GBM, AML, HCC, and CRC, m6A modification can promote or inhibit signaling factors to regulate the physiological activities of cancer cells. The figure illustrates some of these pathways

Back to article page